Lijie Wang

Title: Innovations of Lijie Wang in Gene Editing

Introduction

Lijie Wang is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of gene editing, particularly in the development of technologies that minimize unintended mutations. With a total of two patents to his name, Wang's work is paving the way for safer and more effective gene editing techniques.

Latest Patents

Lijie Wang's latest patents focus on the inhibition of unintended mutations in gene editing. He has developed fusion proteins and related molecules that are useful for conducting base editing with reduced or no off-target mutations. These fusion proteins include a first fragment comprising a nucleobase deaminase or a catalytic domain thereof, and a second fragment comprising a nucleobase deaminase inhibitor. A protease cleavage site is positioned between the first and second fragments. Additionally, Wang has provided improved prime editing systems, which include prime editing guide RNA with enhanced stability.

Career Highlights

Lijie Wang is affiliated with ShanghaiTech University, where he continues to advance research in gene editing technologies. His innovative approaches have garnered attention in the scientific community, contributing to the ongoing evolution of genetic engineering.

Collaborations

Wang collaborates with notable colleagues, including Jia Chen and Bei Yang, who contribute to his research endeavors. Their combined expertise enhances the potential impact of their work in the field of gene editing.

Conclusion

Lijie Wang's contributions to gene editing through his innovative patents and collaborations highlight the importance of reducing unintended mutations in genetic research. His work at ShanghaiTech University is instrumental in shaping the future of gene editing technologies.